Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement
Lanari M
•
Venturini E
•
Pierantoni L
altro
DI Giorgio A
2022